JPS567719A - Drug for prevention and remedy of infection - Google Patents

Drug for prevention and remedy of infection

Info

Publication number
JPS567719A
JPS567719A JP8346880A JP8346880A JPS567719A JP S567719 A JPS567719 A JP S567719A JP 8346880 A JP8346880 A JP 8346880A JP 8346880 A JP8346880 A JP 8346880A JP S567719 A JPS567719 A JP S567719A
Authority
JP
Japan
Prior art keywords
remedy
infection
drug
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8346880A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0152370B2 (enExample
Inventor
Einaa Suteran Ieru Buiruherumu
Mikaeru Buatsudosutor Torukeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20338361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS567719(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of JPS567719A publication Critical patent/JPS567719A/ja
Publication of JPH0152370B2 publication Critical patent/JPH0152370B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP8346880A 1979-06-21 1980-06-21 Drug for prevention and remedy of infection Granted JPS567719A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7905523A SE445013B (sv) 1979-06-21 1979-06-21 Medel for att forebygga eller behandla infektioner hos menniskor och djur

Publications (2)

Publication Number Publication Date
JPS567719A true JPS567719A (en) 1981-01-27
JPH0152370B2 JPH0152370B2 (enExample) 1989-11-08

Family

ID=20338361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8346880A Granted JPS567719A (en) 1979-06-21 1980-06-21 Drug for prevention and remedy of infection

Country Status (6)

Country Link
US (1) US4645757A (enExample)
EP (1) EP0021230B2 (enExample)
JP (1) JPS567719A (enExample)
CA (1) CA1146865A (enExample)
DE (1) DE3071708D1 (enExample)
SE (1) SE445013B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60210256A (ja) * 1984-03-14 1985-10-22 エルイーセー・カーレ・アクチエボラーグ 細菌吸着組成物
WO1997004789A1 (en) * 1995-08-02 1997-02-13 Hisamitsu Pharmaceutical Co., Inc. Tablets containing anion exchange resin

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8204244L (sv) * 1982-07-09 1984-01-10 Ulf Schroder Kristalliserad kolhydratsmatris for biologiskt aktiva substanser
US5189015A (en) * 1984-05-30 1993-02-23 Alfa-Laval Agri International Ab Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5281414A (en) * 1989-07-28 1994-01-25 Stockel Richard F Three-dimensional water disinfectants
JP2911554B2 (ja) * 1990-06-25 1999-06-23 台糖株式会社 抗ウィルス剤
US5440014A (en) * 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
JPH0751209B2 (ja) * 1991-06-06 1995-06-05 ベステクス株式会社 フィルタ材の製造方法
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
DE19631421C2 (de) 1996-08-06 2002-07-18 Beiersdorf Ag Antimikrobielle Wundauflagen
JP4010585B2 (ja) 1996-10-15 2007-11-21 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
PT1635661E (pt) * 2003-06-13 2010-11-17 Torkel Wadstroem Produto para fins de absorção
DE102004035905A1 (de) * 2004-07-20 2006-02-16 Biotronik Vi Patent Ag Magnesiumhaltiges Wundauflagematerial
US9463119B2 (en) 2007-01-18 2016-10-11 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
EP2498820B1 (en) * 2009-11-13 2019-01-09 University of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
US9260536B2 (en) 2011-07-22 2016-02-16 Stellan Hjerten Capture of pathogenic and non-pathogenic biopolymers and bioparticles
US10334897B2 (en) * 2013-11-25 2019-07-02 University Of Maryland, College Park Quick-drying, tacky polymer film compositions and methods of use
EP3934659A4 (en) 2019-03-05 2022-12-14 Medcura, Inc. SYSTEM AND METHOD FOR REDUCING TISSUE OR ORGAN ADHESION

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB386067A (en) * 1931-01-03 1933-01-12 Le Carbone Sa Improvements in or relating to dressings
NL255047A (enExample) * 1959-08-21
US3130126A (en) * 1962-09-14 1964-04-21 Central Pharmacal Company Oral pharmaceutical products prepared with carboxymethyl benzyl dextran having a low carboxymethyl d. s. of 0.15
US3224941A (en) * 1963-01-21 1965-12-21 Lilly Co Eli Resin compositions and method for controlling diarrhea
GB1090421A (en) * 1963-12-13 1967-11-08 Aerosan Ltd Improvements in surgical dressings
US3545442A (en) * 1964-09-23 1970-12-08 Huyck Corp Bandaging and dressing material
FR5705M (enExample) * 1966-08-31 1968-01-15
US3489148A (en) * 1966-12-20 1970-01-13 Procter & Gamble Topsheet for disposable diapers
US3624209A (en) * 1966-12-28 1971-11-30 Bristol Myers Co Composition for treatment of gastro-intestinal disorders
FR6901M (enExample) * 1967-06-23 1969-04-28
US3903268A (en) * 1968-02-12 1975-09-02 Lescarden Ltd Chitin and chitin derivatives for promoting wound healing
FR2077687B1 (enExample) * 1970-02-05 1973-03-16 Roussel Uclaf
US3911116A (en) * 1970-04-13 1975-10-07 Leslie L Balassa Process for promoting wound healing with chitin derivatives
US3914413A (en) * 1971-02-10 1975-10-21 Leslie L Balassa Process for facilitating wound healing with N-acetylated partially depolymerized chitin materials
US3943247A (en) * 1972-05-22 1976-03-09 Kaken Kagaku Kabushiki Kaisha Treatment of bacterial infections with glucan compositions
SE452109B (sv) * 1973-01-29 1987-11-16 Pharmacia Ab Rengoringsmedel for vetskande utvertes sarytor
SE413986B (sv) * 1973-03-23 1980-07-07 Exploaterings Ab Tbf Sett att separera amfipatiska emnen innehallande bade hydrofila och hydrofoba grupper samt gelprodukt for genomforande av separationen
FR2244543B1 (enExample) * 1973-07-27 1977-07-01 Inst Nl Sante Rech Medica
US3965263A (en) * 1973-09-28 1976-06-22 The Purdue Frederick Company Choline salicylate compositions and methods for achieving analgesia
US4002173A (en) * 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
NL159285B (nl) * 1975-01-24 1979-02-15 Tevic Int Bv Vochtabsorberend produkt, voorzien van een laag vochtabsorberend materiaal en een vochtdoorlatende deklaag.
GB1541435A (en) * 1975-02-04 1979-02-28 Searle & Co Immunological materials
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
SE7702261L (sv) * 1976-03-02 1977-09-07 Pharmaco Inc Forfarande for att immobilisera antimikrobiella emnen
US4260602A (en) * 1977-08-16 1981-04-07 Burroughs Wellcome Co. Hapten polysaccharide conjugate medicaments and method of use
US4241054A (en) * 1978-12-08 1980-12-23 The Procter & Gamble Company Detoxifying lipophilic toxins

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60210256A (ja) * 1984-03-14 1985-10-22 エルイーセー・カーレ・アクチエボラーグ 細菌吸着組成物
WO1997004789A1 (en) * 1995-08-02 1997-02-13 Hisamitsu Pharmaceutical Co., Inc. Tablets containing anion exchange resin

Also Published As

Publication number Publication date
SE445013B (sv) 1986-05-26
EP0021230A3 (en) 1981-01-21
JPH0152370B2 (enExample) 1989-11-08
EP0021230B2 (en) 1990-07-25
DE3071708D1 (en) 1986-09-25
US4645757A (en) 1987-02-24
EP0021230A2 (en) 1981-01-07
CA1146865A (en) 1983-05-24
EP0021230B1 (en) 1986-08-20
SE7905523L (sv) 1980-12-22

Similar Documents

Publication Publication Date Title
JPS567719A (en) Drug for prevention and remedy of infection
JPS5643217A (en) Water drug for external application for trauma treatment and manufacture thereof
JPS567714A (en) Pharmaceutical medicine
JPS55155659A (en) Preparation of catheter
PH24427A (en) Treatment of dysmanorrhea
KE3382A (en) Compounds and preparations for the treatment of theileriasis
GB2054588B (en) Amino-ether oxides and pharmaceutical formulations thereof
JPS5655386A (en) *** catechine salts* manufacture of their salts and therapeutic drug containing them
NZ193798A (en) 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
CU35257A (en) Flavone derivatives its preparation procedure and pharmaceutical agents
ZA80269B (en) Pharmaceutical compositions consisting or consisting essentially of liposomers and processes for making same
JPS5262273A (en) Ppoduction of benzisothiazolone and pharmaceutical composition
DE2856901D2 (de) Form of implant medicament and preparation process
JPS5331659A (en) Preparation of perhydrooazaaheterocyclic compound and medical formulations
NZ193078A (en) Derivatives of 9-aminoalkyl-flyorene medicinal preparations
JPS5238023A (en) Drug for protecting plants and preventing noxtous organism
JPS5646821A (en) Releaseecontrolled animal medicine and manufacture of same
IL60325A0 (en) Novel quinazoline derivatives and pharmaceutical preparations containing them
ZA803535B (en) Novel quinazoline derivatives and pharmaceutical preparations
IL59764A0 (en) Drug on the basis of dihydroergo-toxine and procedure for its manufacture
ZA817796B (en) Use of anticholenergic drugs
ZA802578B (en) Preparation of aryl-monourethanes and aryl-polyurethanes
PH16220A (en) Pyrro-lidine derivatives and pharmaceutical compositions thereof
JPS5610118A (en) Nasal medicine and manufacture thereof
NZ194316A (en) Preparation of 15-hydroxyimino-e-homoeburnane derivatives and 15-halo-e-homoeburnane precursors therein